肝癌精确放射治疗中的呼吸运动管理及补偿策略_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 唐瑗玲 ^1,2 ,  王辛 ^1,2

1. ;
2. ;

Corresponding author：

王辛, Email: wangxin213@sina.com

Keywords：

DOI：

10.7507/1007-9424.202012110

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 唐瑗玲, 王辛. 肝癌精确放射治疗中的呼吸运动管理及补偿策略. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2021, 28(3): 292-296. doi: 10.7507/1007-9424.202012110 Copy

1.	Mohammadian M, Allah Bakeshei K, Mohammadian-Hafshejani A. International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future. J Prev Med Hyg, 2020, 61(2): E259-E289.
2.	Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2019, 394(10204): 1145-1158.
3.	Lin L, Yan L, Liu Y, et al. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the global burden of disease study 2017. Liver Cancer, 2020, 9(5): 563-582.
4.	Zheng C, Zeng H, Lin H, et al. Serum microcystin levels positively linked with risk of hepatocellular carcinoma: A case-control study in southwest China. Hepatology, 2017, 66(5): 1519-1528.
5.	Osaki Y, Nishikawa H. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatol Res, 2015, 45(1): 59-74.
6.	Rim CH, Cheng J, Huang WY, et al. An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective. Radiother Oncol, 2020, 148: 73-81.
7.	李居东, 徐新飞, 余炯杰, 等. 《2018 年美国国立综合癌症网络肝胆肿瘤临床实践指南(V1 版)》更新要点及临床路径. 临床肝胆病杂志, 2018, 34(5): 966-977.
8.	原发性肝癌诊疗规范(2019 年版). 传染病信息, 2020, 33(6): 481-500.
9.	Kimura T, Aikata H, Doi Y, Imano N, et al. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies. Technol Cancer Res Treat, 2018, 17: 1533033818783450.
10.	Meng M, Wang H, Zeng X, et al. Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma. Drug Discov Ther, 2015, 9(5): 372-379.
11.	Wong TC, Chiang CL, Lee AS, et al. Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis. Surg Oncol, 2019, 28: 228-235.
12.	Chen SW, Lin LC, Kuo YC, et al. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 2014, 88(5): 1041-1047.
13.	Huo YR, Eslick GD. Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: A systematic review and meta-analysis. JAMA Oncol, 2015, 1(6): 756-765.
14.	Yang J, Cai J, Wang H, et al. Is diaphragm motion a good surrogate for liver tumor motion? Int J Radiat Oncol Biol Phys, 2014, 90(4): 952-958.
15.	Tsai YL, Wu CJ, Shaw S, et al. Quantitative analysis of respiration-induced motion of each liver segment with helical computed tomography and 4-dimensional computed tomography. Radiat Oncol, 2018, 13(1): 59.
16.	Park JC, Park SH, Kim JH, et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys, 2012, 39(10): 6431-6342.
17.	Shirato H, Seppenwoolde Y, Kitamura K, et al. Intrafractional tumor motion: lung and liver. Semin Radiat Oncol, 2004, 14(1): 10-18.
18.	Naumann P, Batista V, Farnia B, et al. Feasibility of optical surface-guidance for position verification and monitoring of stereotactic body radiotherapy in deep-inspiration breath-hold. Front Oncol, 2020, 10: 573279.
19.	常哲兴, 高云东, 张雪峰, 等. 自主呼吸控制技术用于原发性肝癌患者放疗的可行性及安全性分析. 中国民康医学, 2015, 27(2): 59-60.
20.	Mast M, Kouwenhoven E, Roos J, et al. Two years’ experience with inspiration breath-hold in liver SBRT. Tech Innov Patient Support Radiat Oncol, 2018, 7: 1-5.
21.	Eccles C, Brock KK, Bissonnette JP, et al. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys, 2006, 64(3): 751-759.
22.	Lu L, Diaconu C, Djemil T, et al. Intra- and inter-fractional liver and lung tumor motions treated with SBRT under active breathing control. J Appl Clin Med Phys, 2018, 19(1): 39-45.
23.	冯进进, 储开岳, 李明. 简易腹部加压装置技术对减小呼吸运动在原发性肝癌放射治疗摆位误差的影响. 生物医学工程与临床, 2019, 23(5): 545-547.
24.	Eccles CL, Patel R, Simeonov AK, et al. Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys, 2011, 79(2): 602-608.
25.	Hu Y, Zhou YK, Chen YX, et al. 4D-CT scans reveal reduced magnitude of respiratory liver motion achieved by different abdominal compression plate positions in patients with intrahepatic tumors undergoing helical tomotherapy. Med Phys, 2016, 43(7): 4335.
26.	Hu Y, Zhou YK, Chen YX, et al. Magnitude and influencing factors of respiration-induced liver motion during abdominal compression in patients with intrahepatic tumors. Radiat Oncol, 2017, 12(1): 9.
27.	Eccles CL, Dawson LA, Moseley JL, et al. Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression. Int J Radiat Oncol Biol Phys, 2011, 80(3): 938-946.
28.	Heinzerling JH, Anderson JF, Papiez L, et al. Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys, 2008, 70(5): 1571-1578.
29.	Lovelock DM, Zatcky J, Goodman K, et al. The effectiveness of a pneumatic compression belt in reducing respiratory motion of abdominal tumors in patients undergoing stereotactic body radiotherapy. Technol Cancer Res Treat, 2014, 13(3): 259-267.
30.	Guckenberger M, Kavanagh A, Webb S, et al. A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept—a compromise between small safety margins and long duty cycles. Radiother Oncol, 2011, 98(3): 317-322.
31.	Mageras GS, Yorke E. Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatment. Semin Radiat Oncol, 2004, 14(1): 65-75.
32.	Wagman R, Yorke E, Ford E, et al. Respiratory gating for liver tumors: use in dose escalation. Int J Radiat Oncol Biol Phys, 2003, 55(3): 659-668.
33.	Xi M, Zhang L, Liu MZ, et al. Dosimetric analysis of respiratory-gated radiotherapy for hepatocellular carcinoma. Med Dosim, Summer, 2011, 36(2): 213-218.
34.	Dieterich S, Gibbs IC. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol, 2011, 43: 181-194.
35.	Zhang T, Sun J, He W, et al. Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma. BMC Cancer, 2018, 18(1): 451.
36.	Yoon K, Kwak J, Cho B, et al. Gated Volumetric-modulated arc therapy vs. tumor-tracking CyberKnife radiotherapy as stereotactic body radiotherapy for hepatocellular carcinoma: A dosimetric comparison study focused on the impact of respiratory motion managements. PLoS One, 2016, 11(11): e0166927.
37.	Sun J, Zhang A, Li W, et al. CyberKnife stereotactic body radiation therapy as an effective treatment for hepatocellular carcinoma patients with decompensated cirrhosis. Front Oncol, 2020, 10: 100.
38.	Li H, Noel C, Garcia-Ramirez J, et al. Clinical evaluations of an amplitude-based binning algorithm for 4DCT reconstruction in radiation therapy. Med Phys, 2012, 39(2): 922-932.
39.	Werner R, Hofmann C, Mücke E, et al. Reduction of breathing irregularity-related motion artifacts in low-pitch spiral 4D CT by optimized projection binning. Radiat Oncol, 2017, 12(1): 100.
40.	Yeo SG, Kim ES. Efficient approach for determining four-dimensional computed tomography-based internal target volume in stereotactic radiotherapy of lung cancer. Radiat Oncol J, 2013, 31(4): 247-251.
41.	Cao J, Cui Y, Champ CE, et al. Determination of internal target volume using selective phases of a 4-dimensional computed tomography scan. Pract Radiat Oncol, 2012, 2(3): 186-192.
42.	Xi M, Liu MZ, Zhang L, et al. How many sets of 4DCT images are sufficient to determine internal target volume for liver radiotherapy? Radiother Oncol, 2009, 92(2): 255-259.
43.	Borm KJ, Oechsner M, Wiegandt M, et al. Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data. BMC Cancer, 2018, 18(1): 760.
44.	Tian Y, Wang Z, Ge H, et al. Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT. Med Phys, 2012, 39(5): 2754-2760.
45.	Liu J, Wang JZ, Zhao JD, et al. Use of combined maximum and minimum intensity projections to determine internal target volume in 4-dimensional CT scans for hepatic malignancies. Radiat Oncol, 2012, 7: 11.
46.	Gupta A, Kumar R, Yadav HP, et al. Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma. Rep Pract Oncol Radiother, 2020, 25(2): 293-298.
47.	Ma C, Duan J, Yu S, et al. Dosimetric study of three-dimensional static and dynamic SBRT radiotherapy for hepatocellular carcinoma based on 4DCT image deformable registration. J Appl Clin Med Phys, 2020, 21(2): 60-66.

1. Mohammadian M, Allah Bakeshei K, Mohammadian-Hafshejani A. International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future. J Prev Med Hyg, 2020, 61(2): E259-E289.
2. Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2019, 394(10204): 1145-1158.
3. Lin L, Yan L, Liu Y, et al. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the global burden of disease study 2017. Liver Cancer, 2020, 9(5): 563-582.
4. Zheng C, Zeng H, Lin H, et al. Serum microcystin levels positively linked with risk of hepatocellular carcinoma: A case-control study in southwest China. Hepatology, 2017, 66(5): 1519-1528.
5. Osaki Y, Nishikawa H. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review. Hepatol Res, 2015, 45(1): 59-74.
6. Rim CH, Cheng J, Huang WY, et al. An evaluation of hepatocellular carcinoma practice guidelines from a radiation oncology perspective. Radiother Oncol, 2020, 148: 73-81.
7. 李居东, 徐新飞, 余炯杰, 等. 《2018 年美国国立综合癌症网络肝胆肿瘤临床实践指南(V1 版)》更新要点及临床路径. 临床肝胆病杂志, 2018, 34(5): 966-977.
8. 原发性肝癌诊疗规范(2019 年版). 传染病信息, 2020, 33(6): 481-500.
9. Kimura T, Aikata H, Doi Y, Imano N, et al. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies. Technol Cancer Res Treat, 2018, 17: 1533033818783450.
10. Meng M, Wang H, Zeng X, et al. Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma. Drug Discov Ther, 2015, 9(5): 372-379.
11. Wong TC, Chiang CL, Lee AS, et al. Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis. Surg Oncol, 2019, 28: 228-235.
12. Chen SW, Lin LC, Kuo YC, et al. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 2014, 88(5): 1041-1047.
13. Huo YR, Eslick GD. Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: A systematic review and meta-analysis. JAMA Oncol, 2015, 1(6): 756-765.
14. Yang J, Cai J, Wang H, et al. Is diaphragm motion a good surrogate for liver tumor motion? Int J Radiat Oncol Biol Phys, 2014, 90(4): 952-958.
15. Tsai YL, Wu CJ, Shaw S, et al. Quantitative analysis of respiration-induced motion of each liver segment with helical computed tomography and 4-dimensional computed tomography. Radiat Oncol, 2018, 13(1): 59.
16. Park JC, Park SH, Kim JH, et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys, 2012, 39(10): 6431-6342.
17. Shirato H, Seppenwoolde Y, Kitamura K, et al. Intrafractional tumor motion: lung and liver. Semin Radiat Oncol, 2004, 14(1): 10-18.
18. Naumann P, Batista V, Farnia B, et al. Feasibility of optical surface-guidance for position verification and monitoring of stereotactic body radiotherapy in deep-inspiration breath-hold. Front Oncol, 2020, 10: 573279.
19. 常哲兴, 高云东, 张雪峰, 等. 自主呼吸控制技术用于原发性肝癌患者放疗的可行性及安全性分析. 中国民康医学, 2015, 27(2): 59-60.
20. Mast M, Kouwenhoven E, Roos J, et al. Two years’ experience with inspiration breath-hold in liver SBRT. Tech Innov Patient Support Radiat Oncol, 2018, 7: 1-5.
21. Eccles C, Brock KK, Bissonnette JP, et al. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys, 2006, 64(3): 751-759.
22. Lu L, Diaconu C, Djemil T, et al. Intra- and inter-fractional liver and lung tumor motions treated with SBRT under active breathing control. J Appl Clin Med Phys, 2018, 19(1): 39-45.
23. 冯进进, 储开岳, 李明. 简易腹部加压装置技术对减小呼吸运动在原发性肝癌放射治疗摆位误差的影响. 生物医学工程与临床, 2019, 23(5): 545-547.
24. Eccles CL, Patel R, Simeonov AK, et al. Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys, 2011, 79(2): 602-608.
25. Hu Y, Zhou YK, Chen YX, et al. 4D-CT scans reveal reduced magnitude of respiratory liver motion achieved by different abdominal compression plate positions in patients with intrahepatic tumors undergoing helical tomotherapy. Med Phys, 2016, 43(7): 4335.
26. Hu Y, Zhou YK, Chen YX, et al. Magnitude and influencing factors of respiration-induced liver motion during abdominal compression in patients with intrahepatic tumors. Radiat Oncol, 2017, 12(1): 9.
27. Eccles CL, Dawson LA, Moseley JL, et al. Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression. Int J Radiat Oncol Biol Phys, 2011, 80(3): 938-946.
28. Heinzerling JH, Anderson JF, Papiez L, et al. Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys, 2008, 70(5): 1571-1578.
29. Lovelock DM, Zatcky J, Goodman K, et al. The effectiveness of a pneumatic compression belt in reducing respiratory motion of abdominal tumors in patients undergoing stereotactic body radiotherapy. Technol Cancer Res Treat, 2014, 13(3): 259-267.
30. Guckenberger M, Kavanagh A, Webb S, et al. A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept—a compromise between small safety margins and long duty cycles. Radiother Oncol, 2011, 98(3): 317-322.
31. Mageras GS, Yorke E. Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatment. Semin Radiat Oncol, 2004, 14(1): 65-75.
32. Wagman R, Yorke E, Ford E, et al. Respiratory gating for liver tumors: use in dose escalation. Int J Radiat Oncol Biol Phys, 2003, 55(3): 659-668.
33. Xi M, Zhang L, Liu MZ, et al. Dosimetric analysis of respiratory-gated radiotherapy for hepatocellular carcinoma. Med Dosim, Summer, 2011, 36(2): 213-218.
34. Dieterich S, Gibbs IC. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol, 2011, 43: 181-194.
35. Zhang T, Sun J, He W, et al. Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma. BMC Cancer, 2018, 18(1): 451.
36. Yoon K, Kwak J, Cho B, et al. Gated Volumetric-modulated arc therapy vs. tumor-tracking CyberKnife radiotherapy as stereotactic body radiotherapy for hepatocellular carcinoma: A dosimetric comparison study focused on the impact of respiratory motion managements. PLoS One, 2016, 11(11): e0166927.
37. Sun J, Zhang A, Li W, et al. CyberKnife stereotactic body radiation therapy as an effective treatment for hepatocellular carcinoma patients with decompensated cirrhosis. Front Oncol, 2020, 10: 100.
38. Li H, Noel C, Garcia-Ramirez J, et al. Clinical evaluations of an amplitude-based binning algorithm for 4DCT reconstruction in radiation therapy. Med Phys, 2012, 39(2): 922-932.
39. Werner R, Hofmann C, Mücke E, et al. Reduction of breathing irregularity-related motion artifacts in low-pitch spiral 4D CT by optimized projection binning. Radiat Oncol, 2017, 12(1): 100.
40. Yeo SG, Kim ES. Efficient approach for determining four-dimensional computed tomography-based internal target volume in stereotactic radiotherapy of lung cancer. Radiat Oncol J, 2013, 31(4): 247-251.
41. Cao J, Cui Y, Champ CE, et al. Determination of internal target volume using selective phases of a 4-dimensional computed tomography scan. Pract Radiat Oncol, 2012, 2(3): 186-192.
42. Xi M, Liu MZ, Zhang L, et al. How many sets of 4DCT images are sufficient to determine internal target volume for liver radiotherapy? Radiother Oncol, 2009, 92(2): 255-259.
43. Borm KJ, Oechsner M, Wiegandt M, et al. Moving targets in 4D-CTs versus MIP and AIP: comparison of patients data to phantom data. BMC Cancer, 2018, 18(1): 760.
44. Tian Y, Wang Z, Ge H, et al. Dosimetric comparison of treatment plans based on free breathing, maximum, and average intensity projection CTs for lung cancer SBRT. Med Phys, 2012, 39(5): 2754-2760.
45. Liu J, Wang JZ, Zhao JD, et al. Use of combined maximum and minimum intensity projections to determine internal target volume in 4-dimensional CT scans for hepatic malignancies. Radiat Oncol, 2012, 7: 11.
46. Gupta A, Kumar R, Yadav HP, et al. Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma. Rep Pract Oncol Radiother, 2020, 25(2): 293-298.
47. Ma C, Duan J, Yu S, et al. Dosimetric study of three-dimensional static and dynamic SBRT radiotherapy for hepatocellular carcinoma based on 4DCT image deformable registration. J Appl Clin Med Phys, 2020, 21(2): 60-66.

Previous Article
The accuracy of various models in predicting coronary artery disease in the world: A systematic review
Next Article
肝癌的影像学研究进展及其在多学科诊疗中的应用

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

肝癌精确放射治疗中的呼吸运动管理及补偿策略

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content